CURRENT OPENINGS
Cambrex Karlskoga AB is one of four (4) Cambrex facilities which supports the pharmaceutical industry by providing premium drug substance development and manufacturing services.
Cambrex Karlskoga’s available technology platforms are based upon a wide variety of organic chemistry reactions. and concentrates on developing processes and supplying products to pharmaceutical companies. Our services include:
Route Selection – Designing and demonstration of scalable synthetic routes for safe, efficient, and economical commercial processes.
Process Development – Optimizing existing processes with focus on balancing time, quality and cost.
Analytical Development – Supporting our customers’ drug applications and preparing the CMC submission package of INDs and NDAs.
Cambrex Karlskoga specializes in cGMP high energy reactions and our core technologies include hydrogenations, nitric acid oxidations, chiral synthesis and large scale enzymatic transformations.
We primarily produce cGMP active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. We currently provide approximately 20 products the the overall Cambrex proprietary products portfolio. We also do custom manufacturing, which can be manufactured in quantities from one metric ton to 1,500 metric tons per year.
|